340B State Legislation: Texas

Overview

The Texas Legislature is considering HB 3265, which would exacerbate the negative effects of the 340B program on employers and working families. At the same time, it fails to address the program’s lack of transparency – something both the program and Texans urgently need.

The 340B program enables participating hospitals in Texas and across the U.S. to purchase medications at a significant discount and sell them to plan sponsors at the prevailing rate, a “buy low, sell high” scheme that results in hospital profits at the expense of working families. There is no guarantee that hospitals will pass the 340B profits to vulnerable patients in local communities. Working families are already struggling, and they do not need to pay for expensive, marked-up drugs from hospitals.

Together, the National Alliance of Healthcare Purchaser Coalitions and the Texas Business Group on Health urge policymakers to oppose this legislation, which would raise healthcare costs for Texan families and perpetuate health care consolidation by exacerbating the impact of 340B on purchasers and employees.

340B Employer Resources

Explore these additional resources for more information about the impact of 340B and this proposed legislation on working families in Texas.

One-Pager

340B Bill Would Raise Healthcare Costs for Texas Businesses

Learn more about the impact of proposed 340B legislation on businesses in Texas.

Sign On Letter

Businesses Express Concern About TX 340B Legislation

The Texas Business Group on Health led a sign on letter discussing their concerns about the impact of proposed legislation.
quote
"The 340B program is the poster child of a well-intended program that has completely lost its way and is in desperate need of significant new oversight and reform."
Shawn Gremminger
President and CEO of the National Alliance of Healthcare Purchaser Coalitions